Multiple roles for poly(ADP-ribose)polymerase-1 in neurological disease

Neurochemistry International

Volumn 50, Issue 7-8, 2007, Pages 954-958

  Kauppinen, Tiina M ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

DNA repair; Inflammation; Neuronal death; Neuroprotection; PARP 1

Indexed keywords

1,11B DIHYDRO[2H]BENZOPYRANO[4,3,2 DE]ISOQUINOLIN 3 ONE; 1,5 DIHYDROXYISOQUINOLINE; 3 AMINOBENZAMIDE; 3,4 DIHYDRO 5 [4 (1 PIPERIDINYL)BUTOXY] 1(2H) ISOQUINOLINONE; 5 CHLORO 2 [3 (4 PHENYL 3,6 DIHYDRO 1(2H) PYRIDINYL)PROPYL] 4(3H) QUINAZOLINONE; GPI 6150; INDENOISOQUINOLINONE; N (6 OXO 5,6 DIHYDROPHENANTHRIDIN 2 YL) N,N DIMETHYLACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL FUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; DNA REPAIR; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; INFLAMMATION; NERVE CELL NECROSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; UNSPECIFIED SIDE EFFECT;

BRAIN DEATH; CENTRAL NERVOUS SYSTEM DISEASES; DNA REPAIR; ENZYME INHIBITORS; HUMANS; INFLAMMATION; NERVOUS SYSTEM DISEASES; POLY(ADP-RIBOSE) POLYMERASES;

EID: 34250777695     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2006.11.010     Document Type: Article

References (67)

1. + depletion and mitochondrial permeability transition. J. Biol. Chem. 279 (2004) 18895-18902
2. Alano C.C., Kauppinen T.M., Valls A.V., and Swanson R.A. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 9685-9690
3. Andreone T.L., O'Connor M., Denenberg A., Hake P.W., and Zingarelli B. Poly(ADP-ribose) polymerase-1 regulates activation of activator protein-1 in murine fibroblasts. J. Immunol. 170 (2003) 2113-2120
4. Besson V.C., Zsengeller Z., Plotkine M., Szabo C., and Marchand-Verrecchia C. Beneficial effects of PJ34 and INO-1001, two novel water-soluble poly(ADP-ribose) polymerase inhibitors, on the consequences of traumatic brain injury in rat. Brain Res. 1041 (2005) 149-156
5. Butler A.J., and Ordahl C.P. Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription. Mol. Cell. Biol. 19 (1999) 296-306
6. Cervellera M.N., and Sala A. Poly(ADP-ribose) polymerase is a B-MYB coactivator. J. Biol. Chem. 275 (2000) 10692-10696
7. Chang W.J., and Alvarez-Gonzalez R. The sequence-specific DNA binding of NF-kappa B is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1. J. Biol. Chem. 276 (2001) 47664-47670
8. Chiarugi A. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br. J. Pharmacol. 137 (2002) 761-770
9. Chiarugi A., and Moskowitz M.A. Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J. Neurochem. 85 (2003) 306-317
10. Cho I.J., Lee A.K., Lee S.J., Lee M.G., and Kim S.G. Repression by oxidative stress of iNOS and cytokine gene induction in macrophages results from AP-1 and NF-kappaB inhibition mediated by B cell translocation gene-1 activation. Free Radic. Biol. Med. 39 (2005) 1523-1536
11. Cohen-Armon M., Visochek L., Katzoff A., Levitan D., Susswein A.J., Klein R., Valbrun M., and Schwartz J.H. Long-term memory requires polyADP-ribosylation. Science 304 (2004) 1820-1822
12. Czapski G.A., Cakala M., Kopczuk D., and Strosznajder J.B. Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress evoked hydroxyl radical level and macromolecules oxidation in cell free system of rat brain cortex. Neurosci. Lett. 356 (2004) 45-48
13. d'Adda di Fagagna F., Hande M.P., Tong W.M., Roth D., Lansdorp P.M., Wang Z.Q., and Jackson S.P. Effects of DNA nonhomologous end-joining factors on telomere length and chromosomal stability in mammalian cells. Curr. Biol. 11 (2001) 1192-1196
14. D'Amours D., Desnoyers S., D'Silva I., and Poirier G.G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 342 Pt 2 (1999) 249-268
15. Davidovic L., Vodenicharov M., Affar E.B., and Poirier G.G. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp. Cell Res. 268 (2001) 7-13
16. de Murcia G., and Menissier de Murcia J. Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends Biochem. Sci. 19 (1994) 172-176
17. de Murcia G., Schreiber V., Molinete M., Saulier B., Poch O., Masson M., Niedergang C., and Menissier de Murcia J. Structure and function of poly(ADP-ribose) polymerase. Mol. Cell. Biochem. 138 (1994) 15-24
18. Eliasson M.J., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.Q., Dawson T.M., Snyder S.H., and Dawson V.L. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3 (1997) 1089-1095
19. Endres M., Wang Z.Q., Namura S., Waeber C., and Moskowitz M.A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17 (1997) 1143-1151
20. Feng Y., and LeBlanc M.H. Drug-induced hypothermia begun 5 minutes after injury with a poly(adenosine 5′-diphosphate-ribose) polymerase inhibitor reduces hypoxic brain injury in rat pups. Crit. Care Med. 30 (2002) 2420-2424
21. Ha H.C., and Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13978-13982
22. Ha H.C., Hester L.D., and Snyder S.H. Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 3270-3275
23. Halliwell B.G.J. Free Radicals in Biology and Medicine. 2nd ed. (1989), Clarendon, Oxford
24. Hasko G., Mabley J.G., Nemeth Z.H., Pacher P., Deitch E.A., and Szabo C. Poly(ADP-ribose) polymerase is a regulator of chemokine production: relevance for the pathogenesis of shock and inflammation. Mol. Med. 8 (2002) 283-289
25. Hassa P.O., and Hottiger M.O. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell. Mol. Life Sci. 59 (2002) 1534-1553
26. Hassa P.O., Covic M., Hasan S., Imhof R., and Hottiger M.O. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J. Biol. Chem. 276 (2001) 45588-45597
27. Hassa P.O., Haenni S.S., Buerki C., Meier N.I., Lane W.S., Owen H., Gersbach M., Imhof R., and Hottiger M.O. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-kappaB-dependent transcription. J. Biol. Chem. 280 (2005) 40450-40464
28. Hong S.J., Dawson T.M., and Dawson V.L. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signalling. Trends Pharmacol. Sci. 25 (2004) 259-264
29. Huang J.Y., Chen W.H., Chang Y.L., Wang H.T., Chuang W.T., and Lee S.C. Modulation of nucleosome-binding activity of FACT by poly(ADP-ribosyl)ation. Nucleic Acids Res. 34 (2006) 2398-2407
30. Iwashita A., Tojo N., Matsuura S., Yamazaki S., Kamijo K., Ishida J., Yamamoto H., Hattori K., Matsuoka N., and Mutoh S. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazo linone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. J. Pharmacol. Exp. Ther. 310 (2004) 425-436
31. Kannan P., Yu Y., Wankhade S., and Tainsky M.A. PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res. 27 (1999) 866-874
32. Kaplan J., O'Connor M., Hake P.W., and Zingarelli B. Inhibitors of poly(ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration. Shock 23 (2005) 233-238
33. Kauppinen T.M., and Swanson R.A. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J. Immunol. 174 (2005) 2288-2296
34. Kauppinen T.M., Suh S.W., Genain C.P., and Swanson R.A. Poly(ADP-ribose) polymerase-1 activation in a primate model of multiple sclerosis. J. Neurosci. Res. 81 (2005) 190-198
35. Kauppinen T.M., Chan W.Y., Suh S.W., Wiggins A.K., Huang E.J., and Swanson R.A. Direct phosphorylation and regulation of poly(ADP-ribose) polymerase-1 by extracellular signal-regulated kinases 1/2. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 7136-7141
36. Koistinaho J., Yrjanheikki J., Kauppinen T., and Koistinaho M. Tetracycline derivatives as anti-inflammatory agents and potential agents in stroke treatment. Ernst Schering Res Found Workshop (2004) 101-115
37. Kraus W.L., and Lis J.T. PARP goes transcription. Cell 113 (2003) 677-683
38. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
39. LaPlaca M.C., Zhang J., Raghupathi R., Li J.H., Smith F., Bareyre F.M., Snyder S.H., Graham D.I., and McIntosh T.K. Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J. Neurotrauma 18 (2001) 369-376
40. Love S., Barber R., and Wilcock G.K. Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. Brain 122 (1999) 247-253
41. Love S., Barber R., and Wilcock G.K. Neuronal death in brain infarcts in man. Neuropathol. Appl. Neurobiol. 26 (2000) 55-66
42. Mandir A.S., Przedborski S., Jackson-Lewis V., Wang Z.Q., Simbulan-Rosenthal C.M., Smulson M.E., Hoffman B.E., Guastella D.B., Dawson V.L., and Dawson T.M. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5774-5779
43. Mandir A.S., Poitras M.F., Berliner A.R., Herring W.J., Guastella D.B., Feldman A., Poirier G.G., Wang Z.Q., Dawson T.M., and Dawson V.L. NMDA but not non-NMDA excitotoxicity is mediated by poly(ADP-ribose) polymerase. J. Neurosci. 20 (2000) 8005-8011
44. Martin-Oliva D., Aguilar-Quesada R., O'Valle F., Munoz-Gamez J.A., Martinez-Romero R., Garcia Del Moral R., Ruiz de Almodovar J.M., Villuendas R., Piris M.A., and Oliver F.J. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Res. 66 (2006) 5744-5756
45. Masson M., Niedergang C., Schreiber V., Muller S., Menissier-de Murcia J., and de Murcia G. XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol. Cell. Biol. 18 (1998) 3563-3571
46. Modjtahedi N., Giordanetto F., Madeo F., and Kroemer G. Apoptosis-inducing factor: vital and lethal. Trends Cell Biol. 16 (2006) 264-272
47. Nakajima H., Nagaso H., Kakui N., Ishikawa M., Hiranuma T., and Hoshiko S. Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells. J. Biol. Chem. 279 (2004) 42774-42786
48. Nie J., Sakamoto S., Song D., Qu Z., Ota K., and Taniguchi T. Interaction of Oct-1 and automodification domain of poly(ADP-ribose) synthetase. FEBS Lett. 424 (1998) 27-32
49. Oei S.L., and Shi Y. Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage. Biochem. Biophys. Res. Commun. 285 (2001) 27-31
50. Oka J., Ueda K., Hayaishi O., Komura H., and Nakanishi K. ADP-ribosyl protein lyase. Purification, properties, and identification of the product. J. Biol. Chem. 259 (1984) 986-995
51. Oliver F.J., Menissier-de Murcia J., Nacci C., Decker P., Andriantsitohaina R., Muller S., de la Rubia G., Stoclet J.C., and de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18 (1999) 4446-4454
52. Pieper A.A., Verma A., Zhang J., and Snyder S.H. Poly(ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20 (1999) 171-181
53. Pleschke J.M., Kleczkowska H.E., Strohm M., and Althaus F.R. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J. Biol. Chem. 275 (2000) 40974-40980
54. Rouleau M., Aubin R.A., and Poirier G.G. Poly(ADP-ribosyl)ated chromatin domains: access granted. J. Cell Sci. 117 (2004) 815-825
55. Samper E., Goytisolo F.A., Menissier-de Murcia J., Gonzalez-Suarez E., Cigudosa J.C., de Murcia G., and Blasco M.A. Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase-deficient mice and primary cells despite increased chromosomal instability. J. Cell Biol. 154 (2001) 49-60
56. Scott G.S., Hake P., Kean R.B., Virag L., Szabo C., and Hooper D.C. Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 117 (2001) 78-86
57. Suh S.W., Aoyama K., Chen Y., Garnier P., Matsumori Y., Gum E., Liu J., and Swanson R.A. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J. Neurosci. 23 (2003) 10681-10690
58. Ullrich O., Diestel A., Eyupoglu I.Y., and Nitsch R. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat Cell Biol. 3 (2001) 1035-1042
59. Virag L., and Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 54 (2002) 375-429
60. Visochek L., Steingart R.A., Vulih-Shultzman I., Klein R., Priel E., Gozes I., and Cohen-Armon M. PolyADP-ribosylation is involved in neurotrophic activity. J. Neurosci. 25 (2005) 7420-7428
61. Wesierska-Gadek J., Schmid G., and Cerni C. ADP-ribosylation of wild-type p53 in vitro: binding of p53 protein to specific p53 consensus sequence prevents its modification. Biochem. Biophys. Res. Commun. 224 (1996) 96-102
62. Whalen M.J., Clark R.S., Dixon C.E., Robichaud P., Marion D.W., Vagni V., Graham S., Virag L., Hasko G., Stachlewitz R., Szabo C., and Kochanek P.M. Traumatic brain injury in mice deficient in poly-ADP(ribose) polymerase: a preliminary report. Acta Neurochir. Suppl. 76 (2000) 61-64
63. + repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. Biochem. Biophys. Res. Commun. 308 (2003) 809-813
64. + as a metabolic link between DNA damage and cell death. J. Neurosci. Res. 79 (2005) 216-223
65. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., Poirier G.G., Dawson T.M., and Dawson V.L. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297 (2002) 259-263
66. Zhang J., Lautar S., Huang S., Ramsey C., Cheung A., and Li J.H. GPI 6150 prevents H(2)O(2) cytotoxicity by inhibiting poly(ADP-ribose) polymerase. Biochem. Biophys. Res. Commun. 278 (2000) 590-598
67. Zhang JaL J.H. Poly(ADP-ribose) Polymerase Inhibition by Genetic and Pharmacological Means (2002), CRC Press, Boca Raton